Loading…
This event has ended. Visit the official site or create your own event on Sched.

View analytic
Tuesday, June 28 • 4:00pm - 5:15pm
#271: The Things Kids Say: Clinical Outcome Assessments in Pediatric Clinical Trials

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-16-570-L01-P; CME 1.25; IACET 1.25; RN 1.25

Patient perspectives in clinical trials are a regulatory focus. Challenges exist when considering pediatric patients. This forum will further explore FDA guidance, challenges, and solutions regarding clinical outcome assessments/patient-reported outcomes in pediatric clinical trials.

Learning Objectives

Define clinical outcome assessments (COAs), including patient-reported outcomes (PROs), with special attention to the FDA PRO guidance document; Describe possible challenges when implementing pediatric COAs, as exemplified in case studies involving pediatric functional constipation and sickle cell disease; Describe best practice recommendations for the development, selection, and use of COAs in pediatric trials.

Chair

Gina Calarco

Speaker

Overview of Regulatory Perspective of Developing and Utilizing COA/PRO in Pediatric Clinical Trials
Andrew E. Mulberg, MD

Case Studies for the Development of COA/PRO Tools for Use in Pediatric Clinical Trials
Diane Turner-Bowker, PhD



Chair
avatar for Gina Calarco

Gina Calarco

Associate Director, Pediatric Center of Excellence, Quintiles
Gina Calarco is an Associate Director of Project Management and the Deputy Head of the Pediatric Center of Excellence (PCoE) at Quintiles. Ms Calarco completed her BSN at Saint Luke’s College and MPH from the University of Kansas. She is an affiliate member of the American Academy of Pediatrics Section on Advances in Therapeutics and Technology and holds a coordinator certification through ACRP. Her main area of focus and interest throughout... Read More →

Speakers
avatar for Andrew Mulberg

Andrew Mulberg

Deputy Division Director, Gastroenterology and Inborn Errors Products, OND, CDER, FDA
Andrew E. Mulberg, MD, FAAP, CPI, is Associate Professor of Pediatrics University of Pennsylvania and Professor of Pediatrics at Unviersity of Maryland. He has principally edited a book entitled Pediatric Drug Development: Concepts and Applications published in 2009 and 2013 with Wiley-Blackwell Publishing. He is an avid meber of the Chaine des Rotisseurs.
avatar for Diane Turner-Bowker

Diane Turner-Bowker

Director, Patient-Centered Outcomes, Adelphi Values
As Director of Patient-Centered Outcomes at Adelphi Values, Diane Turner-Bowker provides senior scientific leadership on the development of COAs for use in medical product development to support regulatory, payer, and communication strategies, as well as for use in clinical practice to support healthcare initiatives. Diane earned her MA and PhD in experimental psychology from the University of Rhode Island and is a Six Sigma Green Belt.


Tuesday June 28, 2016 4:00pm - 5:15pm
103A Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA